🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Olema Oncology, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
7.22
-0.14 (-1.90%)
At close: Nov 17, 2026, 4:00 PM EST
7.30
+0.08 (1.11%)
Pre-market: Nov 18, 2026, 8:40 AM EST

Olema Oncology Statistics

Total Valuation

Olema Oncology has a market cap or net worth of $632.52 million. The enterprise value is $222.10 million.

Market Cap632.52M
Enterprise Value 222.10M

Important Dates

The last earnings date was Tuesday, November 10, 2026, before market open.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

Olema Oncology has 87.61 million shares outstanding. The number of shares has increased by 18.41% in one year.

Current Share Class 87.61M
Shares Outstanding 87.61M
Shares Change (YoY) +18.41%
Shares Change (QoQ) -3.22%
Owned by Insiders (%) 2.68%
Owned by Institutions (%) 96.58%
Float 59.30M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.71
P/TBV Ratio 1.72
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.01.

Current Ratio 6.12
Quick Ratio 6.03
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -69.77% and return on invested capital (ROIC) is -46.18%.

Return on Equity (ROE) -69.77%
Return on Assets (ROA) -39.82%
Return on Invested Capital (ROIC) -46.18%
Return on Capital Employed (ROCE) -67.98%
Weighted Average Cost of Capital (WACC) 15.30%
Revenue Per Employee n/a
Profits Per Employee -$1.57M
Employee Count150
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -14.05% in the last 52 weeks. The beta is 2.02, so Olema Oncology's price volatility has been higher than the market average.

Beta (5Y) 2.02
52-Week Price Change -14.05%
50-Day Moving Average 8.04
200-Day Moving Average 12.90
Relative Strength Index (RSI) 46.06
Average Volume (20 Days) 1,482,101

Short Selling Information

The latest short interest is 17.12 million, so 19.55% of the outstanding shares have been sold short.

Short Interest 17.12M
Short Previous Month 15.68M
Short % of Shares Out 19.55%
Short % of Float 28.88%
Short Ratio (days to cover) 12.85

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -252.77M
Pretax Income -235.95M
Net Income -235.95M
EBITDA -252.27M
EBIT -252.77M
Earnings Per Share (EPS) -$2.40
Full Income Statement

Balance Sheet

The company has $413.77 million in cash and $3.36 million in debt, with a net cash position of $410.42 million or $4.68 per share.

Cash & Cash Equivalents 413.77M
Total Debt 3.36M
Net Cash 410.42M
Net Cash Per Share $4.68
Equity (Book Value) 368.84M
Book Value Per Share 4.21
Working Capital 354.19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$177.32 million and capital expenditures -$1.12 million, giving a free cash flow of -$178.44 million.

Operating Cash Flow -177.32M
Capital Expenditures -1.12M
Depreciation & Amortization 502,000
Net Borrowing n/a
Free Cash Flow -178.44M
FCF Per Share -$2.04
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Olema Oncology does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -18.41%
Shareholder Yield -18.41%
Earnings Yield -33.25%
FCF Yield -28.21%

Analyst Forecast

The average price target for Olema Oncology is $35.50, which is 391.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target $35.50
Price Target Difference 391.69%
Analyst Consensus Strong Buy
Analyst Count 12
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1